Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries
<p>Development of antimicrobial resistance (AMR) threatens our ability to treat common and life threatening infections. Identifying the emergence of AMR requires strengthening of surveillance for AMR, particularly in low and middle-income countries (LMICs) where the burden of infection is high...
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Formato: | Journal article |
| Publicado em: |
Wellcome Trust
2017
|
| _version_ | 1826296140854722560 |
|---|---|
| author | Seale, A Hutchison, C Fernandes, S Stoesser, N Kelly, H Lowe, B Turner, P Hanson, K Chandler, C Goodman, C Stabler, R Scott, J |
| author_facet | Seale, A Hutchison, C Fernandes, S Stoesser, N Kelly, H Lowe, B Turner, P Hanson, K Chandler, C Goodman, C Stabler, R Scott, J |
| author_sort | Seale, A |
| collection | OXFORD |
| description | <p>Development of antimicrobial resistance (AMR) threatens our ability to treat common and life threatening infections. Identifying the emergence of AMR requires strengthening of surveillance for AMR, particularly in low and middle-income countries (LMICs) where the burden of infection is highest and health systems are least able to respond. This work aimed, through a combination of desk-based investigation, discussion with colleagues worldwide, and visits to three contrasting countries (Ethiopia, Malawi and Vietnam), to map and compare existing models and surveillance systems for AMR, to examine what worked and what did not work.</p> <p>Current capacity for AMR surveillance varies in LMICs, but and systems in development are focussed on laboratory surveillance. This approach limits understanding of AMR and the extent to which laboratory results can inform local, national and international public health policy. An integrated model, combining clinical, laboratory and demographic surveillance in sentinel sites is more informative and costs for clinical and demographic surveillance are proportionally much lower.</p> <p>The speed and extent to which AMR surveillance can be strengthened depends on the functioning of the health system, and the resources available. Where there is existing laboratory capacity, it may be possible to develop 5-20 sentinel sites with a long term view of establishing comprehensive surveillance; but where health systems are weaker and laboratory infrastructure less developed, available expertise and resources may limit this to 1-2 sentinel sites. Prioritising core functions, such as automated blood cultures, reduces investment at each site. Expertise to support AMR surveillance in LMICs may come from a variety of international, or national, institutions. It is important that these organisations collaborate to support the health systems on which AMR surveillance is built, as well as improving technical capacity specifically relating to AMR surveillance. Strong collaborations, and leadership, drive successful AMR surveillance systems across countries and contexts.</p> |
| first_indexed | 2024-03-07T04:11:46Z |
| format | Journal article |
| id | oxford-uuid:c80e6fee-dba3-48ed-9d6b-7b9900106bdd |
| institution | University of Oxford |
| last_indexed | 2024-03-07T04:11:46Z |
| publishDate | 2017 |
| publisher | Wellcome Trust |
| record_format | dspace |
| spelling | oxford-uuid:c80e6fee-dba3-48ed-9d6b-7b9900106bdd2022-03-27T06:49:43ZSupporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countriesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c80e6fee-dba3-48ed-9d6b-7b9900106bddSymplectic Elements at OxfordWellcome Trust2017Seale, AHutchison, CFernandes, SStoesser, NKelly, HLowe, BTurner, PHanson, KChandler, CGoodman, CStabler, RScott, J<p>Development of antimicrobial resistance (AMR) threatens our ability to treat common and life threatening infections. Identifying the emergence of AMR requires strengthening of surveillance for AMR, particularly in low and middle-income countries (LMICs) where the burden of infection is highest and health systems are least able to respond. This work aimed, through a combination of desk-based investigation, discussion with colleagues worldwide, and visits to three contrasting countries (Ethiopia, Malawi and Vietnam), to map and compare existing models and surveillance systems for AMR, to examine what worked and what did not work.</p> <p>Current capacity for AMR surveillance varies in LMICs, but and systems in development are focussed on laboratory surveillance. This approach limits understanding of AMR and the extent to which laboratory results can inform local, national and international public health policy. An integrated model, combining clinical, laboratory and demographic surveillance in sentinel sites is more informative and costs for clinical and demographic surveillance are proportionally much lower.</p> <p>The speed and extent to which AMR surveillance can be strengthened depends on the functioning of the health system, and the resources available. Where there is existing laboratory capacity, it may be possible to develop 5-20 sentinel sites with a long term view of establishing comprehensive surveillance; but where health systems are weaker and laboratory infrastructure less developed, available expertise and resources may limit this to 1-2 sentinel sites. Prioritising core functions, such as automated blood cultures, reduces investment at each site. Expertise to support AMR surveillance in LMICs may come from a variety of international, or national, institutions. It is important that these organisations collaborate to support the health systems on which AMR surveillance is built, as well as improving technical capacity specifically relating to AMR surveillance. Strong collaborations, and leadership, drive successful AMR surveillance systems across countries and contexts.</p> |
| spellingShingle | Seale, A Hutchison, C Fernandes, S Stoesser, N Kelly, H Lowe, B Turner, P Hanson, K Chandler, C Goodman, C Stabler, R Scott, J Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries |
| title | Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries |
| title_full | Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries |
| title_fullStr | Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries |
| title_full_unstemmed | Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries |
| title_short | Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries |
| title_sort | supporting surveillance capacity for antimicrobial resistance laboratory capacity strengthening for drug resistant infections in low and middle income countries |
| work_keys_str_mv | AT sealea supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries AT hutchisonc supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries AT fernandess supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries AT stoessern supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries AT kellyh supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries AT loweb supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries AT turnerp supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries AT hansonk supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries AT chandlerc supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries AT goodmanc supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries AT stablerr supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries AT scottj supportingsurveillancecapacityforantimicrobialresistancelaboratorycapacitystrengtheningfordrugresistantinfectionsinlowandmiddleincomecountries |